Enhanced hepatic de novo lipogenesis due to GK-GKRP disruption may contribute to hepatic lipid accumulation, which plays an important role in the development of MASLD [22]. The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.